DECIBEL THERAPEUTICS INC (DBTX) Forecast, Price Target & Analyst Ratings

NASDAQ:DBTX • US24343R1068

Current stock price

4.91 USD
-0.04 (-0.81%)
At close:
4.91 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DECIBEL THERAPEUTICS INC (DBTX).

Forecast Snapshot

Consensus Price Target

Price Target
$7.78
+ 58.40% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 7, 2023
Period
Q3 / 2023
EPS Estimate
-$0.79
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.78
Upside
+ 58.40%
From current price of $4.91 to mean target of $7.78, Based on 10 analyst forecasts
Low
$5.30
Median
$7.78
High
$10.50

Price Target Revisions

1 Month
-47.05%
3 Months
-42.09%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for DBTX. The average price target is 7.78 USD. This implies a price increase of 58.4% is expected in the next year compared to the current price of 4.91.
The average price target has been revised downward by 42.09% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

DBTX Current Analyst RatingDBTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

DBTX Historical Analyst RatingsDBTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
78.00%
DBTX was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about DBTX.
In the last month the buy percentage fell by 6 points. So the trust of analysts is decreasing.
DBTX was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-08-10BairdDowngrade Outperform -> Neutral
2023-08-09HC Wainwright & Co.Downgrade Buy -> Neutral
2023-06-06HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-12HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-15SVB LeerinkDowngrade Outperform -> Market Perform
2023-03-15HC Wainwright & Co.Reiterate Buy
2023-02-13HC Wainwright & Co.Reiterate Buy
2023-01-23SVB LeerinkMaintains Outperform
2022-11-10CitigroupMaintains Buy
2022-05-17CitigroupMaintains Buy
2021-12-02JonesTradingInitiate Buy
2021-11-15HC Wainwright & Co.Initiate Buy
2021-11-10SVB LeerinkMaintains Outperform
2021-10-22BairdInitiate Outperform
2021-05-14SVB LeerinkMaintains Outperform
2021-03-09BMO CapitalInitiate Outperform
2021-03-09SVB LeerinkInitiate Outperform
2021-03-09BarclaysInitiate Overweight
2021-03-09CitigroupInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 7, 2023
Period
Q3 / 2023
EPS Estimate
-$0.79
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-22.72%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
-100.00%
EPS (1 Month)
0.00%
EPS (3 Months)
-29.92%

Next Earnings Summary

DBTX is expected to report earnings on 11/7/2023. The consensus EPS estimate for the next earnings is -0.79 USD and the consensus revenue estimate is 0 USD.
The next earnings revenue estimate has been revised downward by 100% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
DBTX revenue by date.DBTX revenue by date.
N/AN/AN/A
-100.00%		N/AN/A
146.92%		N/A
81.67%
EBITDA
YoY % growth
DBTX ebitda by date.DBTX ebitda by date.
-36.39M-42.31M
-16.27%		-34.45M
18.58%		-48.818M
-41.71%		-62.495M
-28.02%		N/A
0.74%		N/A
-19.31%		N/A
-22.05%		N/A
-1.73%		N/A
50.83%		N/A
125.06%
EBIT
YoY % growth
DBTX ebit by date.DBTX ebit by date.
-37.86M-44.08M
-16.43%		-36.09M
18.13%		-50.231M
-39.18%		-63.957M
-27.33%		N/A
7.92%		N/A
-34.41%		N/A
-14.83%		N/A
-24.44%		N/A
37.78%		N/A
73.19%
Operating Margin
DBTX operating margin by date.DBTX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
DBTX eps by date.DBTX eps by date.
N/AN/AN/A-2.64-2.51
4.92%		N/A
-15.00%		N/A
5.65%		N/A
36.29%		N/A
11.82%		N/A
65.33%		N/A
125.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.79
-22.72%		-0.83
-31.14%		-0.79
-48.19%		-0.84
-14.58%		-0.80
-1.30%		-0.43
48.15%
Revenue
Q2Q % growth		10.2M
EBITDA
Q2Q % growth		-15.912M
-4.27%		-18.87M
-25.60%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-20.682M
-26.50%		-21.733M
-31.83%		-22.347M
-58.25%		-25.18M
-32.24%		-25.895M
-25.21%		-15.416M
29.07%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

DBTX Yearly Revenue VS EstimatesDBTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2024 2026 2027 2028 100M 200M 300M
DBTX Yearly EPS VS EstimatesDBTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -1 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
9.38%
EPS Next 5 Year
12.33%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
83.11%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-15.53%
EBIT Next 5 Year
4.21%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

DECIBEL THERAPEUTICS INC / DBTX Forecast FAQ

What do analysts expect the price target to be for DECIBEL THERAPEUTICS INC (DBTX)?

10 analysts have analysed DBTX and the average price target is 7.78 USD. This implies a price increase of 58.4% is expected in the next year compared to the current price of 4.91.

When does DECIBEL THERAPEUTICS INC (DBTX) report earnings?

DECIBEL THERAPEUTICS INC (DBTX) will report earnings on 2023-11-07, after the market close.

What are the consensus estimates for DBTX stock next earnings?

The consensus EPS estimate for the next earnings of DECIBEL THERAPEUTICS INC (DBTX) is -0.79 USD and the consensus revenue estimate is 0 USD.

What is the expected long term growth rate for DBTX stock?

The expected long term growth rate for DECIBEL THERAPEUTICS INC (DBTX) is -25.99%.